Max Shenin
Thomas Jefferson University Hospital(US)Jefferson Hospital(US)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Mast cells and histamine, Multiple Sclerosis Research Studies, Systemic Lupus Erythematosus Research
Most-Cited Works
- → A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis(2009)106 cited
- → Gastric Antral Vascular Ectasia in Systemic Sclerosis: Demographics and Disease Predictors(2010)85 cited
- → Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases(2011)49 cited
- → Primary Amyloidosis Causing Diffuse Alveolar Hemorrhage(2010)22 cited
- → The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis(2008)8 cited
- → A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis(2018)1 cited
- → Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: reply(2010)
- → Mycophenolate Mofetil for the Treatment of Systemic Sclerosis(2008)
- → SAT0328 An open-label study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis(2017)
- → Advances in disease-specific treatment of systemic sclerosis(2009)